ロード中...
Unlocking tumor vascular barriers with CXCR3: Implications for cancer immunotherapy
Promising cancer immunotherapeutics depend on mobilization of cytotoxic T cells across tumor vascular barriers through mechanisms that are poorly understood. Recently, we discovered that the CXCR3 chemokine receptor uniquely functions as the master-regulator of cytotoxic CD8(+) T cell extravasation...
保存先:
出版年: | Oncoimmunology |
---|---|
主要な著者: | , , , , , , |
フォーマット: | Artigo |
言語: | Inglês |
出版事項: |
Taylor & Francis
2016
|
主題: | |
オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4910745/ https://ncbi.nlm.nih.gov/pubmed/27467928 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2015.1116675 |
タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|